ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,201 | -87.8% | 10,101 | -81.7% | 0.00% | -83.3% |
| Q2 2023 | $9,814 | -11.5% | 55,082 | -18.1% | 0.01% | +20.0% |
| Q1 2023 | $11,090 | +348.1% | 67,232 | +327.7% | 0.01% | +400.0% |
| Q4 2022 | $2,475 | -100.0% | 15,719 | -69.7% | 0.00% | -88.9% |
| Q3 2022 | $7,816,000 | +1245.3% | 51,904 | +1367.9% | 0.01% | – |
| Q2 2022 | $581,000 | -91.8% | 3,536 | -88.9% | 0.00% | -100.0% |
| Q1 2022 | $7,111,000 | +119.3% | 31,938 | +133.8% | 0.01% | +500.0% |
| Q4 2021 | $3,242,000 | -93.4% | 13,660 | -93.5% | 0.00% | -95.7% |
| Q3 2021 | $49,226,000 | +568.1% | 210,929 | +489.1% | 0.02% | +666.7% |
| Q2 2021 | $7,368,000 | -10.9% | 35,803 | -11.0% | 0.00% | -40.0% |
| Q1 2021 | $8,268,000 | +2451.9% | 40,246 | +2570.6% | 0.01% | – |
| Q4 2020 | $324,000 | -92.0% | 1,507 | -93.2% | 0.00% | -100.0% |
| Q3 2020 | $4,037,000 | -46.9% | 22,089 | -46.4% | 0.00% | -50.0% |
| Q2 2020 | $7,600,000 | -83.5% | 41,227 | -81.9% | 0.01% | -83.8% |
| Q1 2020 | $46,071,000 | +810.3% | 228,334 | +744.2% | 0.04% | +1133.3% |
| Q4 2019 | $5,061,000 | +104.2% | 27,048 | +74.2% | 0.00% | +50.0% |
| Q3 2019 | $2,479,000 | -50.4% | 15,528 | -21.7% | 0.00% | -33.3% |
| Q2 2019 | $4,996,000 | +440.7% | 19,836 | +413.5% | 0.00% | +200.0% |
| Q1 2019 | $924,000 | -87.0% | 3,863 | -87.5% | 0.00% | -80.0% |
| Q4 2018 | $7,098,000 | +75.1% | 30,906 | +115.6% | 0.01% | +66.7% |
| Q3 2018 | $4,054,000 | -75.6% | 14,338 | -74.7% | 0.00% | -80.0% |
| Q2 2018 | $16,624,000 | +1012.7% | 56,608 | +856.5% | 0.02% | +1400.0% |
| Q1 2018 | $1,494,000 | +149.4% | 5,918 | +113.3% | 0.00% | – |
| Q4 2017 | $599,000 | +449.5% | 2,775 | +374.4% | 0.00% | – |
| Q3 2017 | $109,000 | -75.6% | 585 | -77.4% | 0.00% | – |
| Q2 2017 | $447,000 | -22.5% | 2,588 | -31.6% | 0.00% | -100.0% |
| Q1 2017 | $577,000 | +365.3% | 3,784 | +351.0% | 0.00% | – |
| Q4 2016 | $124,000 | +77.1% | 839 | +50.4% | 0.00% | – |
| Q3 2016 | $70,000 | -98.0% | 558 | -98.2% | 0.00% | -100.0% |
| Q4 2015 | $3,483,000 | +426.1% | 31,100 | +412.0% | 0.00% | +300.0% |
| Q3 2015 | $662,000 | +2446.2% | 6,074 | +2124.9% | 0.00% | – |
| Q2 2015 | $26,000 | -29.7% | 273 | -32.1% | 0.00% | – |
| Q1 2015 | $37,000 | -85.3% | 402 | -87.0% | 0.00% | – |
| Q4 2014 | $251,000 | +12.1% | 3,102 | -11.0% | 0.00% | – |
| Q3 2014 | $224,000 | +1393.3% | 3,485 | +1272.0% | 0.00% | – |
| Q2 2014 | $15,000 | -51.6% | 254 | -52.3% | 0.00% | – |
| Q1 2014 | $31,000 | +55.0% | 533 | +62.5% | 0.00% | – |
| Q4 2013 | $20,000 | -96.6% | 328 | -96.2% | 0.00% | -100.0% |
| Q3 2013 | $581,000 | -45.6% | 8,673 | -41.4% | 0.00% | 0.0% |
| Q2 2013 | $1,068,000 | – | 14,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |